SCHEMBL4193735

SCHEMBL4193735

NC(=O)C[S+]([O-])Cc1ccccc1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
METAP2 P50579 1/20 0.38
BCAT2 O15382 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
BRD4 O60885 1/20 0.35
GAA P10253 1/20 0.34
CTNNB1 P35222 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
MAPK8 P45983 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2207696 0.80 TAAR1 (0.39) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL12433152 0.80 PARP10 (0.41) KDM4EALDH1A1KMT2ASIRT1MAPK8
SCHEMBL18323992 0.80 TAAR1 (0.39) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL1196144 0.78 KMT2A (0.46) BCAT2KMT2ARAB9A
SCHEMBL4188735 0.77 GLA (0.38) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL6802553 0.76 SIRT1 (0.36) KDM4EALDH1A1HPGDMAPTTSHR
SCHEMBL10398402 0.75 CES2 (0.43) MAPTTSHRHSD17B10MEN1KMT2A
SCHEMBL29131294 0.75 CES2 (0.43) MAPTTSHRHSD17B10MEN1KMT2A
SCHEMBL2211230 0.75 ALDH1A1 (0.42) KDM4EALDH1A1HPGDKMT2AGAA
SCHEMBL2416330 0.74 KDM4E (0.54) KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071604-B2 Thio-substituted arylmethanesulfinyl derivatives CEPHALON FRANCE (FR) 2011-12-06 US disclosed
US-20090018143-A1 Thio-substituted arylmethanesulfinyl derivatives CEPHALON, INC. (US) 2009-01-15 US disclosed
US-7297817-B2 Thio-substituted arylmethanesulfinyl derivatives CEPHALON FRANCE (FR) 2007-11-20 US disclosed
US-20050256133-A1 Thio-substituted arylmethanesulfinyl derivatives CEPHALON FRANCE (FR) 2005-11-17 US disclosed
EP-1586560-A1 Thio-substituted arylmethanesulfinyl derivatives CEPHALON, INC. (US) 2005-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256133-A1 Thio-substituted arylmethanesulfinyl derivatives HTR1A, SLC6A3, HTR3B KDM4E 1433/4885ALDH1A1 1617/4885HPGD 3501/4885
US-20090018143-A1 Thio-substituted arylmethanesulfinyl derivatives HTR1A, SLC6A3, HTR3B KDM4E 1433/4885ALDH1A1 1617/4885HPGD 3501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.